Treatment of human brucellosis with doxycycline and gentamicin

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 80-84

  Solera, Javier ^a   Espinosa, Alfredo ^a   Martínez Alfaro, Elisa ^a   Sánchez, Lorenzo ^b   Geijo, Paloma ^c   Navarro, Elena ^a   Escribano, Julio ^d   Fernández, José Antonio ^d  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^b Guadalajara Hospital   (Spain)

^c Hospital de Cuenca   (Spain)

^d Hospital General ^*

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GENTAMICIN;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; BRUCELLA MELITENSIS; BRUCELLOSIS; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROWTH INHIBITION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031029956     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.80     Document Type: Article

References (33)

1. Acocella, G., A. Bertrand, J. Beytout, J. B. Durrande, J. A. García Rodríguez, J. Kosmidis, M. Micoud, M. Rey, M. R. Zapata, J. Roux, and J. P. Stahl. 1989. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J. Antimicrob. Chemother. 23:433-439.
2. Al-Kasab, S., M. R. Al-Fagih, S. Al-Yousef, M. A. Ali Khan, P. A. Ribeiro, S. Nazzal, and M. Al-Zaibag. 1988. Brucella infective endocarditis. Successful combined medical and surgical therapy. J. Thorac. Cardiovasc. Surg. 95:862-867.
3. Altman, D. G. 1992. Practical statistics for medical research. Chapman & Hall, London.
4. Alton, G. G., L. M. Jones, and D. E. Pietz. 1975. Laboratory techniques in brucellosis, 2nd ed. World Health Organization, Geneva.
5. Ariza, J., F. Gudiol, R. Pallarés, G. Rufí, and P. Fernández-Viladrich. 1985. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob. Agents Chemother. 28: 548-551.
6. Ariza, Y., F. Gudiol, R. Pallarés, G. Rufí, and P. Fernández-Viladrich. 1985. Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis. J. Infect. Dis. 152:1358-1359.
7. Ariza, J., F. Gudiol, R. Pallares, P. F. Viladrich, G. Rufi, J. Corredoira, and M. R. Miravitlles. 1992. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann. Intern. Med. 117:25-30.
8. Carrillo, C., E. Gotuzzo, J. Adachi, and J. Tolmos. 1993. Sensibilidad anti-microbiana in vitro de cepas de Brucella melitensis aisladas en una área endémica (Lima, Perú). Rev. Esp. Quimioter. 6:309-313.
9. Chan, R., and R. P. Hardiman. 1993. Endocarditis caused hy Brucella melitensis. Med. J. Aust. 158:631-632.
10. Cisneros, J. M., P. Viciana, J. Colmenero, J. Pachon, C. Martínez, and A. Alarcón. 1990. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks and streptomycin for 2 weeks. Antimicrob. Agents Chemother. 34:881-883.
11. Colmenero Castillo, J. D., S. Hernández Marquez, J. M. Reguera Iglesias, F. Cabrera Franquelo, F. Ruiz Diaz, and A. Alonso. 1989. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Chemotherapy (Basel) 35:146-152.
12. Dean, A. G., J. A. Dean, D. Coulombier, K. A. Brendel, D. C. Smith, A. H. Burton, R. C. Dicker, K. Sullivan, R. F. Fagan, and T. C. Arner. 1994. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Ga.
13. Feiz, J. M., H. Sabbaghian, and F. Sohrabi. 1973. A comparative study of therapeutic agents used for treatment of acute brucellosis. Br. J. Clin. Pract. 27:410-413.
14. Food and Agriculture Organization-World Health Organization. 1986. FAO-WHO expert committee on brucellosis sixth report. In World Health Organization technical report series 740. World Health Organization, Geneva.
15. Gargani, G., and A. M. Pacetti. 1986. Sensitivity of 115 strains of the genus Brucella to some antibiotics (cephalosporins, ureidopenicillins and aminoglycosides). Chemioterapia 5:7-13.
16. Hall, W. H. 1990. Modern chemotherapy for brucellosis in humans. Rev. Infect. Dis. 12:1060-1099.
17. Hausler, W. J., Jr., N. P. Moyer, and L. A. Holcomb. 1984. Brucella, p. 382-386. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
18. Leenheer, A. P., and H. J. C. F. Nelis. 1979. Doxycycline determination in human serum and urine by high-performance liquid chromatography. J. Pharm. Sci. 68:999-1002.
19. Lubani, M. M., K. I. Dubin, D. C. Sharda, D. S. Ndhar, C. F. Araj, H. A. Hafez, Q. A. al-Saleh, I. Helin, and M. M. Salhi. 1989. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr. Infect. Dis. J. 8:75-78.
20. Magill, G. B., and J. H. Killough. 1953. Oxytetracycline-streptomycin therapy in brucellosis due to Brucella melitensis. Arch. Intern. Med. 91:204-211.
21. Montejo, J. M., I. Alberola, P. González-Zarate, A. Alvárez, J. Alonso, A. Cánovas, and C. Aguirre. 1993. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin. Infect. Dis. 16:671-676.
22. Novotny, Z., and S. Moeschlin. 1972. Clinical experience with the broad spectrum antibiotic gentamicin (1969-1970). Schweiz. Med. Wochenschr. 102:24-29.
23. Pedro-Botet, J., J. Coll, T. Auguet, and J. Rubiés-Prat. 1992. Brucellosis and HIV infection: a casual association? AIDS 6:1039-1040.
24. Qadri, S. M. H., S. Al-Sedairy, and Y. Ueno. 1990. Antibacterial activity of lomefloxacin against Brucella melitensis. Diagn. Microbiol. Infect. Dis. 13: 277-279.
25. Solera, J., F. Medrano, M. Rodríguez, P. Geijo, and J. Paulino. 1991. Ensayo terapéutico comparativo y multicéntrico de rifampicina y doxiciclina frente a estreptomicina y doxiciclina en la brucelosis humana. Med. Clin. (Barcelona) 96:649-653.
26. Solera, J., M. Rodríguez-Zapata, P. Geijo, J. Largo, J. Paulino, L. Sáez, E. Martínez-Alfaro, L. Sánchez, M. A. Sepúlveda, and M. D. Ruíz-Ribó. 1995. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob. Agents Chemother. 39:2061-2067.
27. Solera, J., A. Espinosa, P. Geijo, E. Martínez-Alfaro, L. Sáez, M. A. Sepúlveda, and M. D. Ruíz-Ribó. 1996. Treatment of human brucellosis with netilmicin and doxycycline. Clin. Infect. Dis. 22:441-445.
28. Spink, W. W. 1964. Host-parasite relationship in brucellosis. Lancet ii:161-164.
29. Tood, K. H., and P. D. Lyde. 1989. Brucellosis and thrombocytopenic purpura: case report and review. Tex. Med. 85:37-38.
30. Valladares, M., P. Viciana, A. Martín, and M. del Nozal. 1993. Brucelosis aguda e infecciön por VIH, una nueva particularidad. Enf. Infecc. Microbiol. Clin. 11:511-512.
31. Waitz, J. A., and M. J. Weinstein. 1969. Recent microbiological studies with gentamicin. J. Infect. Dis. 119:355-359.
32. Young, E. J. 1995. An overview of human brucellosis. Clin. Infect. Dis. 21:283-290.
33. Young, E. J. 1983. Human brucellosis. Rev. Infect. Dis. 5:821-842.